SEMHF (Siemens Healthineers AG) 3-Month Share Buyback Ratio: 0.00% (As of Jun. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SEMHF Siemens Healthineers AG SEMHF
83 GF Score
Price $45.23
GF Value $59.05
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Siemens Healthineers AG 3-Month Share Buyback Ratio?

Siemens Healthineers AG SEMHF -2.93% 83 3-Month Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus rates SEMHF with a GF Score™ of 83/100 and a GF Value™ of $59.05 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Siemens Healthineers AG's current 3-Month Share Buyback Ratio was 0.00%.


Siemens Healthineers AG  (OTCPK:SEMHF) 3-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Siemens Healthineers AG 3-Month Share Buyback Ratio Related Terms


SEMHF vs ABT, SYK, MDT: 3-Month Share Buyback Ratio Comparison

For the Medical Devices subindustry, Siemens Healthineers AG's 3-Month Share Buyback Ratio, along with its competitors' market caps and 3-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siemens Healthineers AG 3-Month Share Buyback Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's 3-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's 3-Month Share Buyback Ratio falls into.


SEMHF
83GF Score
Siemens Healthineers AG SEMHF
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Siemens Healthineers AG 3-Month Share Buyback Ratio Calculation

Siemens Healthineers AG's 3-Month Share Buyback Ratio for the quarter that ended in Jun. 2026 is calculated as

3-Month Share Buyback Ratio=(Shares Outstanding (EOP) (Mar. 2026 ) - Shares Outstanding (EOP) (Jun. 2026 )) / Shares Outstanding (EOP) (Mar. 2026 )
=(1119.199 - 1119.199) / 1119.199
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a 3-Month Share Buyback Ratio of 0.00 mean?
Siemens Healthineers AG (SEMHF) has a 3-Month Share Buyback Ratio of 0.00 as of Jun. 2026. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Siemens Healthineers AG and its competitors.
Is Siemens Healthineers AG's 3-Month Share Buyback Ratio too high?
Siemens Healthineers AG's current 3-Month Share Buyback Ratio is 0.00. Overall, Siemens Healthineers AG has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siemens Healthineers AG's 3-Month Share Buyback Ratio compare to ABT and SYK?
Siemens Healthineers AG's 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Medical Devices & Instruments company?
A good 3-Month Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Siemens Healthineers AG and its competitors. Siemens Healthineers AG's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siemens Healthineers AG stock overvalued right now?
Based on GuruFocus' analysis, Siemens Healthineers AG (SEMHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $59.05, compared to a current price of $45.23 — trading 23.4% below its estimated fair value. The current 3-Month Share Buyback Ratio is 0.00. Siemens Healthineers AG's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For Siemens Healthineers AG (SEMHF), the current 3-Month Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Siemens Healthineers AG (SEMHF) Overvalued in 2026?

Based on GuruFocus' analysis, Siemens Healthineers AG stock appears to be undervalued. The current stock price of $45.23 is trading 23.4% below its estimated GF Value™ of $59.05. GuruFocus considers Siemens Healthineers AG to be Modestly Undervalued.

Key valuation signals for SEMHF:

  • 3-Month Share Buyback Ratio: 0.00
  • GF Value™: $59.05 vs. price of $45.23 (23.4% below fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the SEMHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Siemens Healthineers AG Business Description

Address Siemensstrasse 3, Forchheim, BY, DEU, 91301
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
83GF Score

Get the complete analysis for SEMHF

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$45.23
Price
$59.05
GF Value